Table 2 Association of SAMHD1 protein levels (% positive AML blasts) with patient characteristics at diagnosis

From: Low-level expression of SAMHD1 in acute myeloid leukemia (AML) blasts correlates with improved outcome upon consolidation chemotherapy with high-dose cytarabine-based regimens

 

Spearman correlation coefficient

P

Age (years)

0.081

0.27

PB blast count

0.10

0.34

BM blast count

−0.0061

0.94

WBC

0.230

0.034

Platelets

−0.15

0.17

Hemoglobin

0.091

0.40

LDH

0.36

0.00056

CD34

−0.10

0.37

FLT3-ITD mutation status

0.91a

FLT3-TKD mutation status

0.20a

NPM1 mutation status

0.36a

IDH mutation status

0.10a

DNMT3A mutation status

0.27a

Gender

0.63a

AraC doseb

0.40a

  1. aMann–Whitney U-test
  2. b1.0 g × 5 days vs 1.5 g × 4 days